Northeast Investment Management Acquires 2,685 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Northeast Investment Management boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 89,170 shares of the medical equipment provider’s stock after purchasing an additional 2,685 shares during the quarter. Intuitive Surgical accounts for about 2.1% of Northeast Investment Management’s investment portfolio, making the stock its 12th biggest holding. Northeast Investment Management’s holdings in Intuitive Surgical were worth $46,543,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Massachusetts Financial Services Co. MA bought a new position in shares of Intuitive Surgical during the third quarter worth about $558,807,000. International Assets Investment Management LLC boosted its position in Intuitive Surgical by 49,383.6% during the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after purchasing an additional 1,088,415 shares during the period. FMR LLC grew its stake in Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after buying an additional 838,793 shares during the last quarter. Wilmington Savings Fund Society FSB lifted its holdings in Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after purchasing an additional 552,058 shares during the last quarter. Finally, Strategic Financial Concepts LLC grew its stake in shares of Intuitive Surgical by 50,740.8% in the fourth quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider’s stock valued at $163,202,000 after acquiring an additional 312,056 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $582.98 on Friday. The stock’s fifty day moving average price is $554.85 and its two-hundred day moving average price is $513.96. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The company has a market cap of $207.65 billion, a P/E ratio of 90.95, a P/E/G ratio of 5.67 and a beta of 1.39.

Insider Activity

In other news, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Jamie Samath sold 269 shares of the stock in a transaction on Monday, November 11th. The shares were sold at an average price of $539.89, for a total transaction of $145,230.41. Following the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,727,816.73. The trade was a 2.98 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 5,940 shares of company stock worth $3,333,485. 0.90% of the stock is owned by company insiders.

Analysts Set New Price Targets

ISRG has been the subject of a number of recent analyst reports. CICC Research began coverage on Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 target price for the company. Robert W. Baird boosted their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. Barclays lifted their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, Citigroup boosted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.